We are delighted to announce that HealthScape Advisors has joined Chartis, one of the nation's leading healthcare advisory firms.  Read the press release.

Article | July 3, 2024

CMS Sets New Standards for SSBCI and Supplemental Benefits Across Medicare Advantage Plans

By ,

The Centers for Medicare & Medicaid Services (CMS) recently released a final rule with changes to the Medicare Advantage (MA) and prescription drug program (MA-PD) for Contract Year 2025 (CY2025). CMS’ stated goal for the final rule is to strengthen…

Read More

Article | July 2, 2024

Seeing the Bigger Picture: How Payers and Providers Can Find Common Ground in Medicare Advantage

By ,

A growing number of disputes have arisen between health systems and Medicare Advantage (MA) plans, with 15 health systems finalizing terminations so far this year. Some have resulted in terminating a single plan’s MA contract, while others have terminated the…

Read More

EXECUTIVE BRIEFING | May 13, 2024

CMS is Driving Towards Greater Integration Between Medicare and Medicaid

By ,

The Centers for Medicare & Medicaid Services’ (CMS’) recently released final rule finalized changes to the Medicare Advantage (MA) prescription drug program (MA-PD) for Contract Year 2025 (CY 2025). CMS’ stated goal for the final rule is to strengthen consumer…

Read More

EXECUTIVE BRIEFING | May 1, 2024

CMS Revamps MA Agent and Broker Compensation: Implications from the Final Rule

By ,

The Centers for Medicare and Medicaid Services’ (CMS’) recently released final rule finalizes changes to the Medicare Advantage (MA) prescription drug program (MA-PD) for Contract Year 2025 (CY 25). CMS’ stated goal for the final rule is to strengthen consumer…

Read More

Executive Briefing | February 8, 2024

Less is the New More with Medicare Advantage Supplemental Benefits in 2024

By , , , ,

Medicare Advantage Organizations (MAOs) face an inherent tension to grow despite financial constraints on margin. This pressure makes it difficult to invest in competitive benefit design elements that are known to drive growth, including supplemental benefits. Significant financial headwinds including…

Read More

Executive Briefing | January 9, 2024

Four Pressures Shaping Health Plans in 2024

By , , , , , , ,

Health plans are confronting significant pressure to their financial sustainability, including rising costs, new regulations, and increased competition. Rising medical costs remains an ongoing challenge, with medical expenses outpacing projections in 2023 driven by factors such as post-COVID demand, network…

Read More

Executive Brief | November 28, 2023

Contract Year 2025 Policy and Technical Changes to Medicare Advantage

By ,

CMS recently released its proposed rule for Medicare Advantage Organizations (MAOs) and Part D sponsors for contract year 2025. While the proposed rule outlines meaningful policy and technical changes to the Medicare program (e.g., behavioral health, health equity, agent/broker compensation, D-SNP…

Read More

Executive Brief | November 2, 2023

2024 Star Rating Analysis: The Story Lies Beyond the Outliers

By , , , ,

Introduction The recent publication of 2024 Medicare Advantage (MA) Star ratings confirmed that the regulatory and operating environment for this program will challenge health plans (especially compared to past years) as the Centers for Medicare and Medicaid Services (CMS) shifts…

Read More

Executive Briefing | March 14, 2023

HealthScape Advisors’ Insights on 2023 AEP Performance

By , ,

This brief builds upon last year’s analysis of Medicare’s Annual Enrollment Period (AEP) and highlights results from the most recent enrollment data available1 from the Centers for Medicare and Medicaid Services (CMS) that accounts for 2023 AEP. Where helpful, we’ll compare…

Read More

Executive Briefing | February 14, 2023

Supplemental Benefit Trends 2023

By , ,

Studies have previously suggested that MA members are “sticky” and rarely change coverage; however, this behavior may be changing given the proliferation of product options and availability of rich benefits. For example, at the recent JP Morgan Healthcare Conference, Humana…

Read More